Cargando…
Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients
BACKGROUND: The relationship between cerebrospinal fluid (CSF) biomarkers and the clinical features of idiopathic normal pressure hydrocephalus (iNPH) has been inconclusive. We aimed to evaluate CSF biomarkers reflecting Alzheimer’s disease (AD)-related amyloid β (Aβ) aggregation, tau pathology, neu...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817565/ https://www.ncbi.nlm.nih.gov/pubmed/35123528 http://dx.doi.org/10.1186/s12987-022-00309-z |
_version_ | 1784645674497736704 |
---|---|
author | Lukkarinen, Heikki Jeppsson, Anna Wikkelsö, Carsten Blennow, Kaj Zetterberg, Henrik Constantinescu, Radu Remes, Anne M. Herukka, Sanna-Kaisa Hiltunen, Mikko Rauramaa, Tuomas Nägga, Katarina Leinonen, Ville Tullberg, Mats |
author_facet | Lukkarinen, Heikki Jeppsson, Anna Wikkelsö, Carsten Blennow, Kaj Zetterberg, Henrik Constantinescu, Radu Remes, Anne M. Herukka, Sanna-Kaisa Hiltunen, Mikko Rauramaa, Tuomas Nägga, Katarina Leinonen, Ville Tullberg, Mats |
author_sort | Lukkarinen, Heikki |
collection | PubMed |
description | BACKGROUND: The relationship between cerebrospinal fluid (CSF) biomarkers and the clinical features of idiopathic normal pressure hydrocephalus (iNPH) has been inconclusive. We aimed to evaluate CSF biomarkers reflecting Alzheimer’s disease (AD)-related amyloid β (Aβ) aggregation, tau pathology, neuroinflammation and axonal degeneration in relation to the clinical features of pre- and post-shunt surgery in iNPH patients. METHODS: Mini Mental State Examination (MMSE) scores and gait velocity were evaluated pre- and postoperatively in cohorts of 65 Finnish (FIN) and 82 Swedish (SWE) iNPH patients. Lumbar CSF samples were obtained prior to shunt surgery and analysed for soluble amyloid precursor protein alpha (sAPPα) and beta (sAPPβ); amyloid-β isoforms of 42, 40 and 38 (Aβ(42), Aβ(40), Aβ(38)); total tau (T-tau); phosphorylated tau (P-tau(181)); neurofilament light (NfL) and monocyte chemoattractant protein 1 (MCP1). RESULTS: Preoperative patient characteristics showed no significant differences between patients in the FIN and SWE cohorts. Patients in both cohorts had significantly improved gait velocity after shunt surgery (p < 0.0001). Low CSF T-tau and absence of apolipoprotein E ε4 predicted over 20% gait improvement postoperatively (p = 0.043 and p = 0.008). Preoperative CSF T-tau, P-tau(181) and NfL correlated negatively with MMSE scores both pre- (p < 0.01) and post-surgery (p < 0.01). Furthermore, T-tau, NfL and Aβ(42) correlated with MMSE outcomes (p < 0.05). Low preoperative CSF P-tau(181) (p = 0.001) and T-tau with NfL (p < 0.001 and p = 0.049) best predicted pre- and postoperative MMSE scores greater than or equal to 26. CONCLUSIONS: CSF biomarkers of neurodegeneration appeared to correlate with pre- and postoperative cognition, providing a window into neuropathological processes. In addition, preoperative CSF neurodegeneration biomarkers may have potential in the prediction of gait and cognitive outcomes after shunt surgery. |
format | Online Article Text |
id | pubmed-8817565 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88175652022-02-07 Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients Lukkarinen, Heikki Jeppsson, Anna Wikkelsö, Carsten Blennow, Kaj Zetterberg, Henrik Constantinescu, Radu Remes, Anne M. Herukka, Sanna-Kaisa Hiltunen, Mikko Rauramaa, Tuomas Nägga, Katarina Leinonen, Ville Tullberg, Mats Fluids Barriers CNS Research BACKGROUND: The relationship between cerebrospinal fluid (CSF) biomarkers and the clinical features of idiopathic normal pressure hydrocephalus (iNPH) has been inconclusive. We aimed to evaluate CSF biomarkers reflecting Alzheimer’s disease (AD)-related amyloid β (Aβ) aggregation, tau pathology, neuroinflammation and axonal degeneration in relation to the clinical features of pre- and post-shunt surgery in iNPH patients. METHODS: Mini Mental State Examination (MMSE) scores and gait velocity were evaluated pre- and postoperatively in cohorts of 65 Finnish (FIN) and 82 Swedish (SWE) iNPH patients. Lumbar CSF samples were obtained prior to shunt surgery and analysed for soluble amyloid precursor protein alpha (sAPPα) and beta (sAPPβ); amyloid-β isoforms of 42, 40 and 38 (Aβ(42), Aβ(40), Aβ(38)); total tau (T-tau); phosphorylated tau (P-tau(181)); neurofilament light (NfL) and monocyte chemoattractant protein 1 (MCP1). RESULTS: Preoperative patient characteristics showed no significant differences between patients in the FIN and SWE cohorts. Patients in both cohorts had significantly improved gait velocity after shunt surgery (p < 0.0001). Low CSF T-tau and absence of apolipoprotein E ε4 predicted over 20% gait improvement postoperatively (p = 0.043 and p = 0.008). Preoperative CSF T-tau, P-tau(181) and NfL correlated negatively with MMSE scores both pre- (p < 0.01) and post-surgery (p < 0.01). Furthermore, T-tau, NfL and Aβ(42) correlated with MMSE outcomes (p < 0.05). Low preoperative CSF P-tau(181) (p = 0.001) and T-tau with NfL (p < 0.001 and p = 0.049) best predicted pre- and postoperative MMSE scores greater than or equal to 26. CONCLUSIONS: CSF biomarkers of neurodegeneration appeared to correlate with pre- and postoperative cognition, providing a window into neuropathological processes. In addition, preoperative CSF neurodegeneration biomarkers may have potential in the prediction of gait and cognitive outcomes after shunt surgery. BioMed Central 2022-02-05 /pmc/articles/PMC8817565/ /pubmed/35123528 http://dx.doi.org/10.1186/s12987-022-00309-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lukkarinen, Heikki Jeppsson, Anna Wikkelsö, Carsten Blennow, Kaj Zetterberg, Henrik Constantinescu, Radu Remes, Anne M. Herukka, Sanna-Kaisa Hiltunen, Mikko Rauramaa, Tuomas Nägga, Katarina Leinonen, Ville Tullberg, Mats Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients |
title | Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients |
title_full | Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients |
title_fullStr | Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients |
title_full_unstemmed | Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients |
title_short | Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients |
title_sort | cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817565/ https://www.ncbi.nlm.nih.gov/pubmed/35123528 http://dx.doi.org/10.1186/s12987-022-00309-z |
work_keys_str_mv | AT lukkarinenheikki cerebrospinalfluidbiomarkersthatreflectclinicalsymptomsinidiopathicnormalpressurehydrocephaluspatients AT jeppssonanna cerebrospinalfluidbiomarkersthatreflectclinicalsymptomsinidiopathicnormalpressurehydrocephaluspatients AT wikkelsocarsten cerebrospinalfluidbiomarkersthatreflectclinicalsymptomsinidiopathicnormalpressurehydrocephaluspatients AT blennowkaj cerebrospinalfluidbiomarkersthatreflectclinicalsymptomsinidiopathicnormalpressurehydrocephaluspatients AT zetterberghenrik cerebrospinalfluidbiomarkersthatreflectclinicalsymptomsinidiopathicnormalpressurehydrocephaluspatients AT constantinescuradu cerebrospinalfluidbiomarkersthatreflectclinicalsymptomsinidiopathicnormalpressurehydrocephaluspatients AT remesannem cerebrospinalfluidbiomarkersthatreflectclinicalsymptomsinidiopathicnormalpressurehydrocephaluspatients AT herukkasannakaisa cerebrospinalfluidbiomarkersthatreflectclinicalsymptomsinidiopathicnormalpressurehydrocephaluspatients AT hiltunenmikko cerebrospinalfluidbiomarkersthatreflectclinicalsymptomsinidiopathicnormalpressurehydrocephaluspatients AT rauramaatuomas cerebrospinalfluidbiomarkersthatreflectclinicalsymptomsinidiopathicnormalpressurehydrocephaluspatients AT naggakatarina cerebrospinalfluidbiomarkersthatreflectclinicalsymptomsinidiopathicnormalpressurehydrocephaluspatients AT leinonenville cerebrospinalfluidbiomarkersthatreflectclinicalsymptomsinidiopathicnormalpressurehydrocephaluspatients AT tullbergmats cerebrospinalfluidbiomarkersthatreflectclinicalsymptomsinidiopathicnormalpressurehydrocephaluspatients |